241 — Alibaba Health Information Technology Income Statement
0.000.00%
Last trade - 00:00
- HK$44.39bn
- HK$31.39bn
- CNY26.76bn
- 87
- 21
- 53
- 55
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,096 | 9,596 | 15,518 | 20,578 | 26,763 |
Cost of Revenue | |||||
Gross Profit | 1,331 | 2,231 | 3,617 | 4,108 | 5,701 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,127 | 9,531 | 15,076 | 20,781 | 26,218 |
Operating Profit | -31.2 | 65.1 | 442 | -203 | 545 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -60.8 | 9.09 | 401 | -253 | 551 |
Provision for Income Taxes | |||||
Net Income After Taxes | -91.8 | -15.7 | 343 | -266 | 534 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -81.9 | -6.59 | 349 | -266 | 533 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -81.9 | -6.59 | 349 | -266 | 533 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.008 | -0.004 | 0.021 | -0.038 | 0.035 |